The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | COMM | 008064107 | 68,897 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Akouos, Inc. | COMM | 00973J101 | 7,197 | 1,515,074 | SH | SOLE | 1,515,074 | 0 | 0 | ||
Ascendis Pharma A/S | ADR | 04351P101 | 58,659 | 499,824 | SH | SOLE | 499,824 | 0 | 0 | ||
Bolt Biotherapeutics, Inc. | COMM | 097702104 | 7,547 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Checkmate Pharmaceuticals Inc | COMM | 162818108 | 11,505 | 3,606,707 | SH | SOLE | 3,606,707 | 0 | 0 | ||
Cincor Pharma, Inc. | COMM | 17240Y109 | 97,767 | 5,573,949 | SH | SOLE | 5,573,949 | 0 | 0 | ||
Fusion Pharmaceuticals Inc | COMM | 36118A100 | 607 | 78,066 | SH | SOLE | 78,066 | 0 | 0 | ||
Galera Therapeutics, Inc | COMM | 36338D108 | 7,339 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Inozyme Pharma, Inc. | COMM | 45790W108 | 8,296 | 2,028,308 | SH | SOLE | 2,028,308 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COMM | 48576A100 | 247,550 | 1,952,441 | SH | SOLE | 1,952,441 | 0 | 0 | ||
Natera Inc | COMM | 632307104 | 126,131 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure, Inc | COMM | 65343E108 | 12,985 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana Plc | Ordinary Shares | GB00BYWYV | 2,398 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
Nucana Plc | ADR | 67022C106 | 5,594 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
ObsEva SA | COMM | H5861P103 | 7,172 | 4,749,623 | SH | SOLE | 4,749,623 | 0 | 0 | ||
PDS Biotechnology Corporation | COMM | 70465T107 | 883 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
Synlogic Inc. | COMM | 87166L100 | 1,380 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | ||
Vera Therapeutics, Inc. | CL A | 92337R101 | 74,732 | 3,181,442 | SH | SOLE | 3,181,442 | 0 | 0 | ||
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 26,068 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 | ||
Adicet Bio Inc | COMM | 007002108 | 8,313 | 416,289 | SH | SOLE | 416,289 | 0 | 0 | ||
Amylyx Pharmaceuticals Inc | COMM | 03237H101 | 1,285 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
AstraZeneca PLC | ADR | 046353108 | 36,746 | 553,903 | SH | SOLE | 553,903 | 0 | 0 | ||
Bicycle Therapeutics PLC | ADR | 088786108 | 7,177 | 163,559 | SH | SOLE | 163,559 | 0 | 0 | ||
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 13,611 | 176,533 | SH | SOLE | 176,533 | 0 | 0 | ||
CTI Biopharma Corp | COMM | 12648L601 | 9,119 | 1,952,691 | SH | SOLE | 1,952,691 | 0 | 0 | ||
ChemoCentryx Inc | COMM | 16383L106 | 14,382 | 573,684 | SH | SOLE | 573,684 | 0 | 0 | ||
ChemoCentryx Inc | CALL | 16383L906 | 7,521 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Cytokinetics Inc | COMM | 23282W605 | 2,317 | 62,944 | SH | SOLE | 62,944 | 0 | 0 | ||
Dexcom Inc | COMM | 252131107 | 20,600 | 40,265 | SH | SOLE | 40,265 | 0 | 0 | ||
Fulcrum Therapeutics Inc | COMM | 359616109 | 5,428 | 229,509 | SH | SOLE | 229,509 | 0 | 0 | ||
Geron Corp | COMM | 374163103 | 2,590 | 1,904,762 | SH | SOLE | 1,904,762 | 0 | 0 | ||
Geron Corp | COMM | 374163103 | 1,360 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
Guardant Health Inc | COMM | 40131M109 | 15,897 | 239,995 | SH | SOLE | 239,995 | 0 | 0 | ||
Heron Therapeutics Inc | COMM | 427746102 | 63 | 11,060 | SH | SOLE | 11,060 | 0 | 0 | ||
Horizon Therapeutics PLC | COMM | G46188101 | 24,503 | 232,894 | SH | SOLE | 232,894 | 0 | 0 | ||
Immatics NV | COMM | N44445109 | 10,132 | 1,268,063 | SH | SOLE | 1,268,063 | 0 | 0 | ||
ImmunoGen Inc | COMM | 45253H101 | 6,798 | 1,428,169 | SH | SOLE | 1,428,169 | 0 | 0 | ||
Inhibrx Inc | COMM | 45720L107 | 11,466 | 514,640 | SH | SOLE | 514,640 | 0 | 0 | ||
Insmed Inc | COMM | 457669307 | 126 | 5,368 | SH | SOLE | 5,368 | 0 | 0 | ||
Insulet Corp | COMM | 45784P101 | 284 | 1,066 | SH | SOLE | 1,066 | 0 | 0 | ||
Intercept Pharmaceuticals Inc | COMM | 45845P108 | 1,627 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
Invesco QQQ Trust Series 1 | COMM | 46090E103 | 63,445 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | |
Iveric Bio Inc | COMM | 46583P102 | 17,187 | 1,021,211 | SH | SOLE | 1,021,211 | 0 | 0 | ||
Jounce Therapeutics Inc | COMM | 481116101 | 10,057 | 1,481,219 | SH | SOLE | 1,481,219 | 0 | 0 | ||
Karuna Therapeutics Inc | COMM | 48576A100 | 81 | 636 | SH | SOLE | 636 | 0 | 0 | ||
Mink Therapeutics Inc | COMM | 603693102 | 745 | 331,002 | SH | SOLE | 331,002 | 0 | 0 | ||
Natera Inc | COMM | 632307104 | 98 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
PTC Therapeutics Inc | COMM | 69366J200 | 130 | 3,480 | SH | SOLE | 3,480 | 0 | 0 | ||
Pfizer Inc | COMM | 717081103 | 2,556 | 49,378 | SH | SOLE | 49,378 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 74366E102 | 12,963 | 547,441 | SH | SOLE | 547,441 | 0 | 0 | ||
Protagonist Therapeutics Inc | COMM | 74366E102 | 2,368 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
Protagonist Therapeutics Inc | COMM | 74366E102 | 2,368 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 19,739 | 602,545 | SH | SOLE | 602,545 | 0 | 0 | ||
Regenxbio Inc | COMM | 75901B107 | 20,381 | 614,085 | SH | SOLE | 614,085 | 0 | 0 | ||
Sarepta Therapeutics Inc | COMM | 803607100 | 6,943 | 88,880 | SH | SOLE | 88,880 | 0 | 0 | ||
Sierra Oncology Inc | COMM | 82640U404 | 18,342 | 572,297 | SH | SOLE | 572,297 | 0 | 0 | ||
Spdr S&P Biotech Etf | COMM | 78464A870 | 17,976 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 12,463 | 717,064 | SH | SOLE | 717,064 | 0 | 0 | ||
Travere Therapeutics Inc | COMM | 89422G107 | 16,963 | 658,249 | SH | SOLE | 658,249 | 0 | 0 | ||
United Therapeutics Corp | COMM | 91307C102 | 35,735 | 199,183 | SH | SOLE | 199,183 | 0 | 0 | ||
Vertex Pharmaceuticals Inc | COMM | 92532F100 | 24,793 | 95,003 | SH | SOLE | 95,003 | 0 | 0 | ||
Xencor Inc | COMM | 98401F105 | 7,310 | 273,992 | SH | SOLE | 273,992 | 0 | 0 | ||
Zoetis Inc | COMM | 98978V103 | 20,099 | 106,574 | SH | SOLE | 106,574 | 0 | 0 | ||
iShares Russell 2000 ETF | COMM | 464287655 | 30,791 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 |